116 related articles for article (PubMed ID: 9036839)
21. Cinnamoyl- and hydroxycinnamoyl amides of glaucine and their antioxidative and antiviral activities.
Spasova M; Philipov S; Nikolaeva-Glomb L; Galabov AS; Milkova Ts
Bioorg Med Chem; 2008 Aug; 16(15):7457-61. PubMed ID: 18590964
[TBL] [Abstract][Full Text] [Related]
22. Advances in antiviral nucleoside analogues and their prodrugs.
Seley-Radtke K; Deval J
Antivir Chem Chemother; 2018; 26():2040206618781410. PubMed ID: 29890841
[No Abstract] [Full Text] [Related]
23. Synthesis and biological activity of N-2,3-dihydroxypropyl-N-4-chlorobutyl nucleoside phosphoramidate prodrugs.
Wu W; Borch RF
Mol Pharm; 2006; 3(4):451-6. PubMed ID: 16889439
[TBL] [Abstract][Full Text] [Related]
24. Lactate cannot substitute for alanine in d4T-based anti-HIV nucleotide prodrugs--despite efficient esterase-mediated hydrolysis.
McGuigan C; Cahard D; Ballatore C; Siddiqui A; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 1998 Nov; 8(21):2949-54. PubMed ID: 9873653
[TBL] [Abstract][Full Text] [Related]
25. Design of anticancer prodrugs for reductive activation.
Chen Y; Hu L
Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of new lipophilic ipomeanol analogues and their cytotoxic activities.
Krauss J; Unterreitmeier D
Arch Pharm (Weinheim); 2005 Jan; 338(1):44-8. PubMed ID: 15674804
[TBL] [Abstract][Full Text] [Related]
27. Single-triggered trimeric prodrugs.
Haba K; Popkov M; Shamis M; Lerner RA; Barbas CF; Shabat D
Angew Chem Int Ed Engl; 2005 Jan; 44(5):716-20. PubMed ID: 15657968
[No Abstract] [Full Text] [Related]
28. Structure-based organic synthesis of drug prototypes: a personal odyssey.
Hanessian S
ChemMedChem; 2006 Dec; 1(12):1301-30. PubMed ID: 17091524
[No Abstract] [Full Text] [Related]
29. Synthesis and biological evaluation of abietic acid derivatives.
González MA; Correa-Royero J; Agudelo L; Mesa A; Betancur-Galvis L
Eur J Med Chem; 2009 Jun; 44(6):2468-72. PubMed ID: 19217699
[TBL] [Abstract][Full Text] [Related]
30. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
[TBL] [Abstract][Full Text] [Related]
31. Rational design of polymerase inhibitors as antiviral drugs.
Oberg B
Antiviral Res; 2006 Sep; 71(2-3):90-5. PubMed ID: 16820225
[TBL] [Abstract][Full Text] [Related]
32. Structure-activity relationships for dipeptide prodrugs of acyclovir: implications for prodrug design.
Santos CR; Capela R; Pereira CS; Valente E; Gouveia L; Pannecouque C; De Clercq E; Moreira R; Gomes P
Eur J Med Chem; 2009 Jun; 44(6):2339-46. PubMed ID: 18848738
[TBL] [Abstract][Full Text] [Related]
33. Ester prodrugs of cyclic 1-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-5-azacytosine: synthesis and antiviral activity.
Krecmerová M; Holý A; Pohl R; Masojídková M; Andrei G; Naesens L; Neyts J; Balzarini J; De Clercq E; Snoeck R
J Med Chem; 2007 Nov; 50(23):5765-72. PubMed ID: 17948980
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of 3'- and 5'-nitrooxy pyrimidine nucleoside nitrate esters: "nitric oxide donor" agents for evaluation as anticancer and antiviral agents.
Naimi E; Zhou A; Khalili P; Wiebe LI; Balzarini J; De Clercq E; Knaus EE
J Med Chem; 2003 Mar; 46(6):995-1004. PubMed ID: 12620076
[TBL] [Abstract][Full Text] [Related]
35. [Design, synthesis and anti-HBV activity of L-amino acid ester prodrugs of acyclic nucleoside phosphonates].
Fu XZ; Jiang SH; Yang YS; Ji RY
Yao Xue Xue Bao; 2008 May; 43(5):495-503. PubMed ID: 18717337
[TBL] [Abstract][Full Text] [Related]
36. Discovery of novel arylethynyltriazole ribonucleosides with selective and effective antiviral and antiproliferative activity.
Wan J; Xia Y; Liu Y; Wang M; Rocchi P; Yao J; Qu F; Neyts J; Iovanna JL; Peng L
J Med Chem; 2009 Feb; 52(4):1144-55. PubMed ID: 19170598
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis, and antitumor activity of bile acid-polyamine-nucleoside conjugates.
Wu D; Ji S; Wu Y; Ju Y; Zhao Y
Bioorg Med Chem Lett; 2007 Jun; 17(11):2983-6. PubMed ID: 17416522
[TBL] [Abstract][Full Text] [Related]
38. Pronucleotides: toward the in vivo delivery of antiviral and anticancer nucleotides.
Wagner CR; Iyer VV; McIntee EJ
Med Res Rev; 2000 Nov; 20(6):417-51. PubMed ID: 11058891
[TBL] [Abstract][Full Text] [Related]
39. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
[TBL] [Abstract][Full Text] [Related]
40. cycloSal-d4TMP pronucleotides structural variations, mechanistic insights and antiviral activity.
Meiera C; Renzea J; Ducho C; Balzarini J
Curr Top Med Chem; 2002 Oct; 2(10):1111-21. PubMed ID: 12173970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
